Research library / Longevity compounds
DD Mostly mechanistic or early data. Shown openly. How we grade →RCT (crossover, double-blind) · 10 people with heart failure, 4 weeks per period
Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial
T Jamialahmadi, M Hasanpour, F Vakilian, P Penson, M Iranshahy, A Sahebkar. Reviews on Recent Clinical Trials. 2024.
- In plain language
- 500 mg twice a day did not change ejection fraction, other heart measures, pro-BNP or C-reactive protein; HDL cholesterol rose.
- Limits
- 10 patients, 4 weeks per period; funding statement not accessible to us.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Urolithin A and mitochondria
- Source
- doi.org/10.2174/0115748871279354240209101604 · PubMed 38415449
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.